Monopar Therapeutics Inc. (MNPR)
undefined
undefined%
At close: undefined
25.38
0.16%
After-hours Dec 13, 2024, 04:00 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15
Revenue - - - - - - - - -
Cost of Revenue - - - - - - - - -
Gross Profit - - - - - - - - -
Operating Income -8.83M -10.54M -9.13M -6.51M -4.32M -3.40M -16.60M -1.19M -688.56K
Interest Income 429.04M 21.24K 24.02K 81.90K 98.89K 103.22K 48.26K 7.23K 1.25K
Pretax Income -8.40M -10.52M -9.10M -6.30M -4.22M -3.30M -16.55M -1.19M -687.31K
Net Income -8.40M -10.49M -9.08M -6.22M -4.13M -3.23M -16.55M -1.19M -687.31K
Selling & General & Admin 3.23M 2.95M 2.63M 2.44M 2.36M 1.63M 1.17M 912.47K 587.08K
Research & Development 5.60M 7.59M 6.49M 4.07M 1.97M 1.77M 15.44M 280.36K 101.49K
Other Expenses - - - - - - 14.50M - -
Operating Expenses 8.83M 10.54M 9.13M 6.51M 4.32M 3.40M 16.60M 1.19M 688.56K
Interest Expense - - - - - 103.22K 48.26K 7.23K -
Selling & Marketing Expenses -3.23B - - - - - - - -
Cost & Expenses 8.83M 10.54M 9.13M 6.51M 4.32M 3.40M 16.60M 1.19M 688.56K
Income Tax - -21.24K -24.02K -81.90K -98.89K -71.61K -2.10M 800.00 -688.56K
Shares Outstanding (Basic) 14.51M 12.72M 12.47M 10.96M 10.59M 10.42M 10.42M 10.42M 10.59M
Shares Outstanding (Diluted) 14.51M 12.72M 12.47M 10.96M 10.59M 10.42M 10.42M 10.42M 10.59M
EPS (Basic) -0.58 -0.83 -0.73 -0.57 -0.39 -0.31 -1.59 -0.11 -0.06
EPS (Diluted) -0.58 -0.83 -0.73 -0.57 -0.39 -0.31 -1.59 -0.11 -0.06
EBITDA 429.04K - - - - - -16.55M 8.03K 1.25K
Depreciation & Amortization 8.83M 10.54M 9.13M 6.51M 4.32M 3.33M 2.10M 1.19M 688.56K